Keyphrases
20(S)-ginsenoside Rh2
100%
Oral Bioavailability
100%
Efflux Mechanism
100%
P-glycoprotein (P-gp)
100%
Absorption Mechanism
100%
Intestinal Perfusion
66%
Madin-Darby Canine Kidney (MDCK) Cells
66%
Multidrug Resistance Protein 1 (MDR1)
66%
Cyclosporine
66%
Overexpressing
66%
P-glycoprotein Inhibitor
66%
Absorbing States
33%
Chemoprevention
33%
Intracellular Concentration
33%
Pharmacokinetics
33%
FVB Mice
33%
Transcellular Transport
33%
Parental Resistance
33%
Caco-2
33%
Caco-2 Cells
33%
Steady-state Plasma Concentration
33%
Verapamil
33%
Wild Mice
33%
Low Oral Bioavailability
33%
Following Model
33%
Drug Resistance Gene
33%
Perfusion Model
33%
Cmax
33%
Oral Absorption
33%
Efflux Ratio
33%
Biochemistry, Genetics and Molecular Biology
Ginsenoside
100%
P-Glycoprotein
100%
Absorption
100%
A J Mouse
60%
Wild Type
40%
Intestine Perfusion
40%
Ciclosporin
40%
Blood Plasma
20%
Pharmacokinetic
20%
Efflux Ratio
20%
Oral Absorption
20%
Transcytosis
20%
Blood Level
20%
Multidrug Resistance
20%
FVB Mouse
20%
Steady State
20%
Wild Type Mouse
20%
Verapamil
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
100%
Ginsenoside Rh 2
100%
Effusion
100%
P-Glycoprotein
60%
A J Mouse
60%
Glycoprotein P Inhibitor
40%
Ciclosporin
40%
Multidrug Resistance Protein 1
40%
Pharmacokinetic
20%
Transcellular Transport
20%
Verapamil
20%
Multidrug Resistance
20%
FVB Mouse
20%
Wild Type Mouse
20%
Transcytosis
20%
Immunology and Microbiology
Absorption
100%
P-Glycoprotein
100%
A J Mouse
60%
Wild Type
40%
Ciclosporin
40%
Intestine Perfusion
40%
Multidrug Resistance Protein 1
40%
Wild Type Mouse
20%
Oral Absorption
20%
Multidrug Resistance
20%
Steady State
20%
Pharmacokinetic
20%
FVB Mouse
20%
Transcytosis
20%
Blood Level
20%
Blood Plasma
20%
Efflux Ratio
20%